Wall Street Indexes Dip With Focus on Trump Policies, Economic Data
The Dow Jones Industrial Average fell 382.15 points, or 0.86%, to 43,910.98, the S&P 500 lost 17.36 points, or 0.29%, to ...
Novavax: Balancing Potential and Risk Amid Strategic Shifts and Uncertain Market Outlook
Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...
Le Lézard1d
Novavax to Participate in Jefferies London Healthcare Conference
2020-2030" report has been added to ResearchAndMarkets.com's offering. Global Clingwrap Machine Market was... Novavax, Inc. , a global company advancing protein-based vaccines with its Matrix-Mtm ...
Novavax: Navigating Fiscal Challenges and Strategic Shifts Amid COVID Vaccine Market Uncertainty
In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...
Honolulu Star-Advertiser1d
Wall Street indexes dip with focus on economic data
Biotech firm Novavax dropped after cutting its annual revenue forecast due to lower-than-expected sales of its COVID-19 ...
devdiscourse1d
Healthcare Headlines: Legal Battles, Financial Shifts, and Market Trends
This article summarizes key developments in the health sector including a lawsuit blocking UnitedHealth's purchase of ...
cidrap.umn1d
Cardiac inflammation markers show role of long-COVID symptoms
Novavax yesterday announced that the US Food and Drug Administration ... Asian Development Bank / Flickr cc The FDA announced ...
cidrap.umn1d
FDA removes clinical trial hold on Novavax COVID-flu combo and flu vaccines
Novavax yesterday announced that the US Food and Drug Administration ... Asian Development Bank / Flickr cc The FDA announced ...
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...
Becker's Hospital Review2d
FDA lifts clinical hold on combined COVID-19-influenza vaccine trials
With the clinical hold now lifted, Novavax plans to resume trial activities and begin enrolling participants for the planned phase 3 studies, the release said. The hold had been imposed Oct. 16 ...
Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again
Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.